Cities Bet on Biotech

States are spending a lot of money to woo biotech companies to their cities, despite the long odds, says the New York Times. The North Carolina Research Campus, also called the Biopolis, cost $500 million; Florida, particularly Palm Beach County, has spent $510 million to entice research institutes to head there (and Scripps and Torrey Pines did); and New York City is putting $45 million into science infrastructure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.